Key facts
- This page summarizes Sanjay Subramanian's Form 4 filing for Inozyme Pharma, Inc. (INZY).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 20 Apr 2022, 16:05.
Sanjay Subramanian - 19 Apr 2022 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)
- Role
- SVP, CFO
- Signature
- /s/ Sanjay Subramanian
- Issuer symbol
- INZY
- Transactions as of
- 19 Apr 2022
- Net transactions value
- +$99,999
- Form type
- 4
- Filing time
- 20 Apr 2022, 16:05:23 UTC
- Previous filing
- 22 Mar 2022
- Next filing
- 27 Mar 2023
- SEC
- View on sec.gov
Key filing fact
Sanjay Subramanian filed Form 4 for Inozyme Pharma, Inc. (INZY) on 20 Apr 2022.
Change
- Previous filing in this sequence was filed on 22 Mar 2022.
- Current net transaction value: +$99,999.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
INZY
transaction
Common Stock
Purchase
- Transaction value
- $99,999
- Shares
- +27,100
- Change %
- Price
- $3.69
- Shares after
- 27,100
- Date
- 19 Apr 2022
- Ownership
- Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.